Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ISHNA POOJARY-HOHMAN

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1245542653
CMS profile
193172
Location
NEW ORLEANS, LA

General Payments · PY2019–2024

$1,960.78

  • Reported across 25 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,188.09

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $800.00 1
Food and Beverage $388.09 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $105.86 1
PY2022 $61.56 2
PY2023 $605.27 5
PY2024 $1,188.09 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201920222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $23.92 05/05/2024 Food and Beverage Undisputed 01/23/2026 1078890325 CMS
ANI Pharmaceuticals, Inc. $31.86 04/11/2024 Food and Beverage Undisputed 01/23/2026 1091153480 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.85 06/11/2024 Food and Beverage Undisputed 01/23/2026 1117931919 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.81 07/16/2024 Food and Beverage Undisputed 01/23/2026 1117931921 CMS
Melinta Therapeutics, LLC $26.05 03/13/2024 Food and Beverage Undisputed 01/23/2026 1140485301 CMS
Merck Sharp & Dohme LLC $14.53 04/22/2024 Food and Beverage Undisputed 01/23/2026 1141663025 CMS
Mylan Specialty L.P. $22.15 03/25/2024 Food and Beverage Undisputed 01/23/2026 1147336388 CMS
PFIZER INC. $800.00 02/15/2024 Consulting Fee Undisputed 01/23/2026 1131585462 CMS
Shionogi Inc $18.92 02/08/2024 Food and Beverage Undisputed 01/23/2026 1154339946 CMS
Shionogi Inc $20.26 03/12/2024 Food and Beverage Undisputed 01/23/2026 1154339884 CMS
Shionogi Inc $17.28 05/09/2024 Food and Beverage Undisputed 01/23/2026 1154339912 CMS
Tactile Systems Technology Inc $19.73 09/10/2024 Food and Beverage Undisputed 01/23/2026 1082363393 CMS
United Therapeutics Corporation $15.23 03/05/2024 Food and Beverage Undisputed 01/23/2026 1149464510 CMS
United Therapeutics Corporation $17.93 05/20/2024 Food and Beverage Undisputed 01/23/2026 1149467234 CMS
United Therapeutics Corporation $33.47 06/13/2024 Food and Beverage Undisputed 01/23/2026 1149467912 CMS
United Therapeutics Corporation $52.57 06/25/2024 Food and Beverage Undisputed 01/23/2026 1149454960 CMS
United Therapeutics Corporation $26.53 09/09/2024 Food and Beverage Undisputed 01/23/2026 1149470722 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.